The efficacy and safety of the standardized herbal combination prepara
tion Enteroplant(R), consisting of peppermint oil (90 mg) and caraway
oil (50 mg) in an enteric coated capsule, have been studied in a doubl
e-blind, placebo-controlled multicentre trial in patients with non-ulc
er dyspepsia. A total of 45 patients were included in the trial after
thorough physical and gastro-enterological examination. The primary ou
tcome variables were the change in the intensity of pain and the globa
l clinical impression (Clinical Global Impressions [CGI], Item 2), whi
ch were evaluated for 39 patients (test preparation: 19, placebo: 20).
After four weeks of treatment both target parameters were significant
ly improved for the group of patients treated with the peppermint oil/
caraway oil combination compared to the placebo group (p = 0.015 and 0
.008, respectively). Before the start of treatment all patients in the
test preparation group reported moderate to severe pain, while by the
end of the study 63.2 % od these patients were free from pain. The pa
in symptoms had improved in a total of 89.5 % of the patients in the a
ctive treatment group. After 4 weeks the Clinical Global Impressions w
ere improved for 94.5 % of the patients treated with the peppermint oi
l/caraway oil combination. The trial medication was also superior to p
lacebo with respect to pain frequency, medical prognosis, the severity
of the disorder and the efficacy index (CGI, Items 1 and 3), which we
re adopted as secondary end-points for evaluation of efficacy. There w
ere similarly favourable findings for the herbal combination, compared
with placebo, with respect to the reduction of other gastrointestinal
symptoms. The combination preparation was found to be excellently tol
erated. There was a total of 7 adverse events (test preparation: 4, pl
acebo: 3), with a causal association with the treatment being ascribed
in one case for the test preparation group and one case for the place
bo group.